Production and characterization of a chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells as a vaccine candidate against COVID-19
Article in PLOS ONE (September 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Article in PLOS ONE (September 2023)
Article in Antimicrobial Resistance & Infection Control (September 2023)
Article in JMIR Public Health and Surveillance (September 2023)